Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation

被引:36
作者
Nozawa, T
Inoue, H
Iwasa, A
Okumura, K
Lee, JD
Shimizu, A
Hayano, M
Yano, K
机构
[1] Toyama Med & Pharmaceut Univ, Dept Internal Med 2, Toyama 9300194, Japan
[2] Hirosaki Univ, Dept Internal Med 2, Hirosaki, Aomori, Japan
[3] Fukui Med Univ, Dept Internal Med 1, Fukui, Japan
[4] Yamaguchi Univ, Sch Med, Fac Hlth Sci, Ube, Yamaguchi 755, Japan
[5] Nagasaki Univ, Dept Internal Med 3, Nagasaki 852, Japan
关键词
anticoagulants; antiplatelet agents; atrial fibrillation; stroke prevention;
D O I
10.1253/circj.68.29
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Elevation of hemostatic markers may account for the increased risk of ischemic stroke in patients with non-valvular atrial fibrillation (NVAF). The aim of this study was to determine the effects of anticoagulation intensity on hemostatic markers in patients with NVAF. Methods and Results In 509 patients with NVAF, comprising 263 patients treated with warfarin and 246 patients without warfarin, the hemostatic markers of prothrombin fragment F1.2 (F1.2), fibrin D-dimer, platelet factor 4 (PF4), and beta-thromboglobulin were determined and compared with those in 111 patients with sinus rhythm. F1.2 was inversely related with anticoagulation intensity and D-dimer increased with age. All hemostatic markers' except F1.2, were greater in patients with NVAF than in patients with sinus rhythm. F1.2 and D-dimer were significantly lower in patients with international normalized ratio (INR) greater than or equal to1.5 than in NVAF patients without warfarin and were not different between NVAF patients with INR of 1.5-1.9 and with INR greater than or equal to2.0. Conclusions Low intensity of anticoagulation (INR 1.5-1.9) suppresses the elevated concentration of F1.2 and D-dimer in patients with NVAF, and might be favorable in Japanese patients with NVAF in view of the balance between prevention of thromboembolism and the adverse effect by warfarin (ie, bleeding).
引用
收藏
页码:29 / 34
页数:6
相关论文
共 30 条
[1]  
Blackshear JL, 1996, LANCET, V348, P633
[2]   MECHANISM OF DIURETIC RESPONSE ASSOCIATED WITH ATRIAL TACHYCARDIA [J].
BOYKIN, J ;
CADNAPAPHORNCHAI, P ;
MCDONALD, KM ;
SCHRIER, RW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1975, 229 (06) :1486-1491
[3]   MECHANISM OF POLYURIA AND NATRIURESIS IN ATRIOVENTRICULAR NODAL TACHYCARDIA [J].
CANEPAANSON, R ;
WILLIAMS, M ;
MARSHALL, J ;
MITSUOKA, T ;
LIGHTMAN, S ;
SUTTON, R .
BRITISH MEDICAL JOURNAL, 1984, 289 (6449) :866-868
[4]   NO EFFECT OF ACETYLSALICYLIC-ACID ON B-THROMBOGLOBULIN AND PLATELET FACTOR-IV PLASMA-LEVELS IN PATIENTS WITH TRANSIENT ISCHEMIC ATTACKS [J].
CARRIERI, P ;
OREFICE, G ;
INDACO, A .
STROKE, 1986, 17 (06) :1153-1155
[5]  
Chesebro JH, 1996, ARCH INTERN MED, V156, P409
[6]   WARFARIN IN THE PREVENTION OF STROKE ASSOCIATED WITH NONRHEUMATIC ATRIAL-FIBRILLATION [J].
EZEKOWITZ, MD ;
BRIDGERS, SL ;
JAMES, KE ;
CARLINER, NH ;
COLLING, CL ;
GORNICK, CC ;
KRAUSESTEINRAUF, H ;
KURTZKE, JF ;
NAZARIAN, SM ;
RADFORD, MJ ;
RICKLES, FR ;
SHABETAI, R ;
DEYKIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (20) :1406-1412
[7]   Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation [J].
Feinberg, WM ;
Cornell, ES ;
Nightingale, SD ;
Pearce, LA ;
Tracy, PT ;
Hart, RG ;
Bovill, EG .
STROKE, 1997, 28 (06) :1101-1106
[8]   Markers of thrombin and platelet activity in patients with atrial fibrillation - Correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study [J].
Feinberg, WM ;
Pearce, LA ;
Hart, RG ;
Cushman, M ;
Cornell, ES ;
Lip, GYH ;
Bovill, EG .
STROKE, 1999, 30 (12) :2547-2553
[9]   COAGULATION-FACTORS AND THE INCREASED RISK OF STROKE IN NONVALVULAR ATRIAL-FIBRILLATION [J].
GUSTAFSSON, C ;
BLOMBACK, M ;
BRITTON, M ;
HAMSTEN, A ;
SVENSSON, J .
STROKE, 1990, 21 (01) :47-51
[10]  
HANDIN RI, 1978, J LAB CLIN MED, V91, P340